Research suggests that medical mistakes kill more people than any cause other than heart disease and cancer. » Read More
J&J was ordered to pay $55 million to a woman who said that using the company's talc-powder products caused her to develop cancer.
Martin Shkreli made an appearance at the U.S. Federal Court in Brooklyn for a hearing related to securities fraud charges.
Pfizer has approached U.S. cancer drug maker Medivation to express interest in an acquisition, raising the possibility of a bid.
Drugmaker Biogen said on Tuesday it intends to spin off its hemophilia drug business as an independent, publicly traded company.
Pfizer reported a 19.7 percent rise in quarterly revenue, boosted by sales of its new treatments for cancer and its Hospira acquisition.
Quintiles Transnational and IMS Health said they would merge, creating a company with a market value of more than $17.6 billion.
Presentations have always been stressful, but failing tech can affect productivity and mental health, according to research into stress.
GlaxoSmithKline CEO Andrew Whitty thinks his company's success has been a product of being patient and investing in innovation.
African-Americans were much less likely to undergo potentially life-saving surgery in Georgia if they lived in heavily segregated areas.
Hedge fund manager Bill Ackman defended his key holding Valeant Pharmaceuticals on Monday, as its shares continued to tumble.
A drug company previously headed by Martin Shkreli was sued for allegedly breaching a contract that let it sell Daraprim. USA Today reports.
Sarepta Therapeutics shares soared Monday after the stock was upgraded to "outperform" at Oppenheimer.
The hedge fund manager says he aims to bring a "meaningful" turnaround and touted embattled drugmaker Valeant's new chief executive.
Berkshire Hathaway Vice-Chairman Charlie Munger had some harsh words to say about Valeant Pharmaceuticals.
Biotech stocks dragged on the market Friday, and some "Fast Money" traders contended the pain may not be done.
A top public health official told CNBC that the U.S. could very well see more instances of the Zika virus.
Puerto Rico's health secretary says the island has recorded its first Zika-related death amid an outbreak of the mosquito-borne virus.
Gilead Sciences fell nearly 8 percent, dragging down the S&P 500’s health care sector.
Quest Diagnostics said it has received emergency authorization from U.S. regulators to sell the first commercially developed diagnostic test for Zika.
Diagnostic test maker Alere said it has rejected a request by Abbott Laboratories to terminate the $5.8 billion deal to buy Alere for a breakup fee.
Get the best of CNBC in your inbox